Alps Advisors Inc Portfolio Holdings

Alps Advisors Inc

  • $14.5 Billion
  • Q2 2024

Alps Advisors Inc has filed its 13F form on August 13, 2024 for Q2 2024 where it was disclosed a total value porftolio of $14.5 Billion distributed in 1012 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Energy Transfer LP with a value of $1.16B, Plains All American Pipeline LP with a value of $1.14B, Mplx LP with a value of $1.11B, Enterprise Products Partners L.P. with a value of $1.11B, and Western Midstream Partners, LP with a value of $1.11B.

Examining the 13F form we can see an increase of $433M in the current position value, from $14.1B to 14.5B.

Alps Advisors Inc is based out at Denver, CO

Below you can find more details about Alps Advisors Inc portfolio as well as his latest detailed transactions.

Portfolio value $14.5 Billion
Energy: $10.1 Billion
ETFs: $1.04 Billion
Technology: $591 Million
Financial Services: $480 Million
Healthcare: $457 Million
Consumer Cyclical: $450 Million
Utilities: $394 Million
Industrials: $383 Million
Other: $627 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$717M
$628,000 0.0% of portfolio
74,598
Q2 2024 New
$3.53B
$649,000 0.0% of portfolio
30,597
Q2 2024 Reduced 4.92%
$5.34B
$126,000 0.0% of portfolio
39,272
Q2 2024 Reduced 4.92%
$551M
$506,000 0.0% of portfolio
47,074
Q2 2024 Added 10.8%
$10.8B
$454,000 0.0% of portfolio
419
Q1 2024 Reduced 11.6%
$1.59B
$410,000 0.0% of portfolio
6,550
Q2 2024 Added 5,017.19%
$104M
$235,000 0.0% of portfolio
115,342
Q2 2024 Reduced 0.5%
$12.7B
$672,000 0.0% of portfolio
46,363
Q2 2024 Reduced 4.92%
$1.92B
$319,000 0.0% of portfolio
7,886
Q2 2024 Reduced 0.55%
$1.89B
$385,000 0.0% of portfolio
6,806
Q2 2024 Reduced 0.45%
$559M
$366,000 0.0% of portfolio
8,711
Q2 2024 Reduced 0.56%
$44.5B
$349,000 0.0% of portfolio
3,818
Q2 2024 Reduced 0.26%
Mineralys Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 33.62%
$6.85B
$425,000 0.0% of portfolio
4,250
Q2 2024 Reduced 0.49%
$20B
$255,000 0.0% of portfolio
860
Q1 2024 New
$13.2B
$530,000 0.0% of portfolio
6,962
Q2 2024 Added 2.35%
$27.6B
$291,000 0.0% of portfolio
5,842
Q2 2024 Reduced 0.6%
Disc Medicine Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 13.34%
$5.19B
$373,000 0.0% of portfolio
849
Q1 2024 Reduced 15.27%
$46.3B
$261,000 0.0% of portfolio
1,721
Q2 2024 Reduced 1.71%
$675M
$381,000 0.0% of portfolio
9,393
Q2 2024 Reduced 0.5%
$1.12B
$337,000 0.0% of portfolio
10,938
Q2 2024 Reduced 0.55%
$3.86B
$275,000 0.0% of portfolio
17,845
Q2 2024 Added 10.87%
$175M
$343,000 0.0% of portfolio
1,109,001
Q2 2024 Added 126.02%
$4.58B
$369,000 0.0% of portfolio
14,565
Q2 2024 Reduced 0.54%
$17.5B
$334,000 0.0% of portfolio
1,355
Q2 2024 Reduced 0.07%
$1.19B
$232,000 0.0% of portfolio
9,015
Q2 2024 Reduced 0.46%
$81.6B
$330,000 0.0% of portfolio
1,903
Q2 2024 Reduced 0.42%
$1.41B
$709,000 0.0% of portfolio
204,916
Q2 2024 Added 163.49%
$82.1B
$721,000 0.0% of portfolio
2,985
Q2 2024 Reduced 20.51%
$33.6B
$314,000 0.0% of portfolio
580
Q2 2024 Reduced 1.19%
$319M
$343,000 0.0% of portfolio
31,117
Q2 2024 Reduced 4.92%
$5.83B
$318,000 0.0% of portfolio
5,341
Q2 2024 Reduced 0.54%
$1.58B
$410,000 0.0% of portfolio
15,394
Q2 2024 Reduced 4.91%
$10.3B
$353,000 0.0% of portfolio
858
Q1 2024 Reduced 25.2%
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
$30.3B
$374,000 0.0% of portfolio
1,873
Q2 2024 Reduced 0.37%
$388M
$310,000 0.0% of portfolio
4,154
Q2 2024 Reduced 0.57%
$1.11B
$275,000 0.0% of portfolio
6,970
Q2 2024 Reduced 17.61%
$14.9B
$352,000 0.0% of portfolio
2,545
Q2 2024 Reduced 0.59%
$1.41B
$212,000 0.0% of portfolio
26,130
Q2 2024 Added 56.33%
$643M
$701,000 0.0% of portfolio
130,710
Q2 2024 Reduced 81.45%
$1.47B
$308,000 0.0% of portfolio
6,428
Q2 2024 Reduced 0.5%
$1.41B
$312,000 0.0% of portfolio
8,654
Q2 2024 Added 15.79%
$7.13B
$327,000 0.0% of portfolio
3,222
Q2 2024 Reduced 0.56%
$1.42B
$325,000 0.0% of portfolio
23,737
Q2 2024 Reduced 0.52%
$38.6B
$293,000 0.0% of portfolio
1,858
Q2 2024 Reduced 1.17%
$357M
$259,000 0.0% of portfolio
14,834
Q2 2024 Reduced 3.42%
$50.5B
$254,000 0.0% of portfolio
2,609
Q2 2024 Added 12.51%

Summary

  • Portfolio
  • No. of Stocks 1,012
  • Current Value $14.5 Billion
  • Prior Value $14.1 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 13, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 46 stocks
  • Additional Purchases 356 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 526 stocks
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email